Exploratory Oncology Resaerch and Clinical Trial Center

Jump to Main Contents

2018年3月9日: WHO Classification of Tumours Series appoints Dr Ochiai to Editorial Board
2018年2月14日: A secondary RET mutation in the activation loop conferring
resistance to vandetanib through allosteric effects

Click on each group's logo, you can wathch the research abstruct.

Group for Clinical Research

Div. of Experimental Therapeutics

Group for Translational Research

Div. of Biomarker Discovery

Div. of Translational Genomics

Div. of Innovative Pathology and Laboratory Medicine

Div. of Clinical Pharmacology and Translational Research

Div. of Cancer Immunology

Group for Innovative Cancer Treatment

Div. of Cancer Immunotherapy

Div. of Supportive Care Research

Div. of Psycho-Oncology

Div. of Pathology

Div. of Developmental Therapeutics

Group for Innovative Diagnostic and Therapeutic Device

Div. of Science and Technology for Endoscopy

Div. of Surgical Technology

(Tsukiji)
(Kashiwa)

Div. of BNCT Medical Research

Div. of Radiation Oncology and Particle Therapy

Div. of Functional Imaging

Experimental Animals

Section of Support of Animal Experimentation

Section of Experimental Animals

We will promote collaborative research with the outside more in future.
If you would like to inquire about our research, please contact the following contact.
Your inquiries will be accepted at the secretariat of EPOC. It will be anonymized as necessary.

Secretariat of EPOC

Inquire About Collaborative Research

Secretariat of EPOC
Mailaddress : EPOC_HP●east.ncc.go.jp (● replace to @)